Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 6/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 3/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6442206 | 0.87 | ADAM17 (0.56) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL18863244 | 0.82 | ADAM17 (0.51) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL28242054 | 0.82 | ADAM17 (0.46) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL31298892 | 0.82 | KDM4E (0.47) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL31039203 | 0.82 | ADAM17 (0.46) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL20773874 | 0.82 | PARK7 (0.50) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL29507053 | 0.82 | PARK7 (0.50) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL8347364 | 0.82 | ADAM17 (0.48) | ADAM17MEN1KMT2AGAACASP3 | |
| SCHEMBL27086033 | 0.82 | PTGS1 (0.49) | ADAM17MEN1KMT2APOLBTNF | |
| SCHEMBL30817456 | 0.82 | MEN1 (0.64) | MEN1KMT2AGAACASP3APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655296-A1 | CBL-B INHIBITORS | Aurigene Oncology Limited (IN) | 2025-12-03 | — | — | EP | disclosed |
| WO-2024156938-A1 | CBL-B INHIBITORS | ORION CORPORATION (FI) | 2024-08-02 | — | — | WO | disclosed |